Tranquis Therapeutics announces initiation of Ph1 study of TQS-168

Clinical Impact
Written By Frances Benson

https://www.tranquis.com/pressrelease/tranquis-therapeutics-announces-initiation-of-phase-1-study-of-tqs-168/

Frances Benson
Previous

Arcellx presents continued robust long-term responses from its CART-ddBCMA Ph1 expansion trial
Next

Nomic Bio raises $17M in Series A